Sfoglia per AUTORE
ZINZANI PL
Collezione AOU Novara

  

Items : 11

2022
AOU Novara

Stefoni V; Zinzani PL; Petrini M; Tisi MC; Tani M; Kovalchuk S; Arcari A; Rosignoli C; Musuraca G; Pozzi S; Cantonetti M; Luzi D; Pane F; D'Alò F; Gini G; Visco C; Margiotta Casaluci G; Cuneo A; Patti C; Stefani PM; Broccoli A; Argnani L; Casadei B;

Real-world Outcomes of Relapsed/Refractory Diffuse Large B-cell Lymphoma Treated With Polatuzumab Vedotin-based Therapy. in HemaSphere / Hemasphere. 2022 Nov 11;6(12):e798. doi: 10.1097/HS9.0000000000000798. eCollection 2022 Dec.
2022
AOU Novara

Gherlinzoni F; Minoia C; Rossi FG; Lucchini E; Pennese E; Dessi' D; Ferrarini I; Scalzulli PR; Salerno M; Musso M; Nizzoli ME; Flenghi L; Masia F; Tisi MC; Bruna R; Puccini B; Fabbri A; Pellegrini C; Broccoli A; Argnani L; Musto P; Patti C; Stefoni V; Zinzani PL;

Role of radiotherapy to bulky sites of advanced Hodgkin lymphoma treated with ABVD: final results of FIL HD0801 trial. in Blood advances / Blood Adv. 2021 Nov 9;5(21):4504-4514. doi: 10.1182/bloodadvances.2021005150.
2021
AOU Alessandria
AOU Città della Salute di Torino
AOU Novara

Zinzani PL; Ciccone G; Freilone R; Rota-Scalabrini D; Zilioli VR; Botto B; Simontacchi G; Tani M; Zaja F; Abruzzese E; Rigacci L; Santoro A; Pulsoni A; Franzone P; Grapulin L; Nassi L; Frezza GP; Zanni M; Pavone V; Nardella A; Buglione M; Re A; Filippi AR; Gioia DM; Gotti M; Sacchetti GM; Evangelista A; Ricardi U; Levis M; et alii...

Vemurafenib plus Rituximab in Refractory or Relapsed Hairy-Cell Leukemia. in The New England journal of medicine / N Engl J Med. 2021 May 13;384(19):1810-1823. doi: 10.1056/NEJMoa2031298.
2021
AOU Novara

Tiacci E; De Carolis L; Simonetti E; Capponi M; Ambrosetti A; Lucia E; Antolino A; Pulsoni A; Ferrari S; Zinzani PL; Ascani S; Perriello VM; Rigacci L; Gaidano G; Della Seta R; Frattarelli N; Falcucci P; Foà R; Visani G; Zaja F; Falini B;

2021
AOU Alessandria
AO Ordine Mauriziano
AOU Città della Salute di Torino
AOU Novara

Piciocchi A; Cuneo A; Foà R; Rigolin GM; Fazi P; Neri A; Guarini A; Raponi S; Nanni M; De Propris MS; Della Starza I; Ibatici A; Murru R; Ruocco V; Del Giudice I; Varettoni M; Molinari A; Gentile M; Chiarenza A; Laurenti L; Gottardi D; Zinzani PL; Gozzetti A; Tani M; Musuraca G; Orsucci L; Re F; Di Renzo N; Liberati AM; et alii...

Venetoclax Shows Low Therapeutic Activity in BCL2-Positive Relapsed/Refractory Peripheral T-Cell Lymphoma: A Phase 2 Study of the Fondazione Italiana Linfomi. in Frontiers in oncology / Front Oncol. 2021 Dec 6;11:789891. doi: 10.3389/fonc.2021.789891. eCollection 2021.
2021
AOU Novara

Ballotta L; Zinzani PL; Pileri S; Bruna R; Tani M; Casadei B; Tabanelli V; Volpetti S; Luminari S; Corradini P; Lucchini E; Tisi MC; Merli M; Re A; Varettoni M; Pesce EA; Zaja F;

2016
AOU Città della Salute di Torino
AOU Novara

Paulli M; Santucci M; Zinzani PL; Pimpinelli N; Rupoli S; Gambacorta M; Ascani S; Fierro MT; Onida F; Fraternali-Orcioni G; Zerbinati N; Cabras MG; Franceschetti S; Rattotti S; Alaibac M; Ramponi A; Grandi V; Dallera E; Arra M; Riboni R; Quaglino P; Tomasini C; Goteri G; Klersy C; Maffi A; Croci GA; Arcaini L; Berti E; Lucioni M; et alii...

Romidepsin in relapsed/refractory T-cell lymphomas: Italian experience and results of a named patient program. in Leukemia & lymphoma / Leuk Lymphoma. 2016 Oct;57(10):2370-4. doi: 10.3109/10428194.2015.1137292. Epub 2016 Feb 17.
2016
AOU Novara

Zinzani PL; Pellegrini C; Cerciello G; Monaco F; Volpetti S; Peli A; Angelucci E; Corradini P; Cox MC; Guarini A; Musso M; Bresciani P; Amato G; Billio A; Caparrotti G; Figuera A; Nassi L; Gaudio F; Grossi A; Onida F; Merli M; Rigacci L; Argnani L;

Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia. in Blood / Blood. 2015 Oct 15;126(16):1921-4. doi: 10.1182/blood-2015-05-647925. Epub 2015 Aug 14.
2015
AO Ordine Mauriziano
AOU Città della Salute di Torino
AOU Novara

Gaidano G; Gattei V; Foà R; Cuneo A; Montillo M; Massaia M; Zinzani PL; Del Poeta G; Perbellini O; Moreno C; Marasca R; Tedeschi A; Neri A; Motta M; Coscia M; Rigolin GM; Vincelli I; Del Giudice I; Gentile M; Laurenti L; Forconi F; Zaja F; Morabito F; Cortelezzi A; Mauro FR; Visco C; Chiarenza A; Bulian P; Ghilardi G; et alii...

Clinical activity of everolimus in relapsed/refractory marginal zone B-cell lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group. in British journal of haematology / Br J Haematol. 2014 Jul;166(1):69-76. doi: 10.1111/bjh.12845. Epub 2014 Mar 27.
2014
AOU Novara

Conconi A; Raderer M; Franceschetti S; Devizzi L; Ferreri AJ; Magagnoli M; Arcaini L; Zinzani PL; Martinelli G; Vitolo U; Kiesewetter B; Porro E; Stathis A; Gaidano G; Cavalli F; Zucca E;

Clinical activity of bortezomib in relapsed/refractory MALT lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group (IELSG). in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2011 Mar;22(3):689-695. doi: 10.1093/annonc/mdq416. Epub 2010 Sep 1.
2011
AOU Novara

Conconi A; Martinelli G; Lopez-Guillermo A; Zinzani PL; Ferreri AJM; Rigacci L; Devizzi L; Vitolo U; Luminari S; Cavalli F; Zucca E;